Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-020761

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Mar 15, 2018
Accepted (ET)
Mar 19, 2018 · 8:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 15, 2018P508,474$29.50A4,138,893IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses